NCT07486817
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07486817
Title Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Royal North Shore Hospital St Leonards New South Wales 2065 Australia Details
Cabrini Health Malvern Victoria 3144 Australia Details
Fiona Stanley Hospital Murdoch Western Australia 6150 Australia Details
Guangdong Provincial People's Hospital Guangzhou 510080 China Details
Shanghai Geriatric Medical Center Shanghai 201104 China Details
CTR Leon Berard Lyon 69373 France Details
INS Curie Paris 75005 France Details
Universitätsklinikum Köln (AöR) Cologne 50937 Germany Details
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg Heidelberg 69126 Germany Details
Kindai University Hospital Osaka, Sakai 590-0197 Japan Details
National Cancer Center Hospital Tokyo, Chuo-ku 104-0045 Japan Details
Severance Hospital Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Hospital Universitari Vall D Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Virgen del Rocío Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field